Measles vaccines, new developments and immunization strategies

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1726-1729

  Wild, T F ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; VIRUS VACCINE;

CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; IMMUNIZATION; INFECTION CONTROL; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PRIORITY JOURNAL; PROMOTER REGION; VACCINE PRODUCTION; VIRUS INHIBITION;

ANIMALS; HUMANS; IMMUNIZATION; MEASLES VACCINE; VACCINES, DNA;

EID: 0345435052     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00428-9     Document Type: Conference Paper

References (29)

1. Enders J.F., Peebles T.C. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 86:1954;277-286.
2. Whittle H.C., Mann G., Eccles M., O'Neill K., Jupp L., Hanlon L., Marsh V. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet. 1:1988;963-966.
3. Tidjani O., Grunitsky B., Guérin N., Lévy-Bruhl D., Lecam N., Xuereff C., Tatagan K. Serological effects of Edmonston-Zagreb, Schwartz and AIK-C vaccine strains given at ages 4-5 or 8-10 months. Lancet. 2:1989;1357-1360.
4. Markowitz L.E., Sepulveda J., Diaz-Ortega J.L., Valdespino J.L., Albrecht P., Zell E.R., Stewart J., Zarate M.L., Bernier R.H. Immunization of six-month old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. New Engl. J. Med. 322:1990;580-587.
5. Rota J.S., Wang Z.D., Rota P., Bellini W.J. Comparison of sequences of th H, F and N coding genes of measles virus vaccine strains. Virus Res. 31:1994;317-330.
6. de Quadros C.A., Olivé J.M., Hersh B.S., Strassburg M.A., Henderson D.A., Brandling-Bennett D., Alleyne G.A.O. Measles elimination in the Americas: evolving strategies. JAMA. 275(3):1996;224-229.
7. Pedersen I.R., Mardhorst C.H., Gilkmann G., von Magnus H. Subclinical measles virus infection in vaccinated seropositive individuals in arctic Greenland. Vaccine. 7:1989;345-348.
8. Edmonson M., Addiss D., McPherson J., Berg J., Circo S., Davis J. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. J. Am. Med. Assoc. 163:1990;2467-2471.
9. Siber G.R., Werner B.G., Halsey N.A., Reid R., Almeido-Hill J., Garrett S.C., Thompson C., Santosham M. Interference of immune globulin with measles and rubella immunization. J. Pediatr. 122(2):1993;204-211.
10. Cutts F.T., Clements C.J., Bennett J.V. Alternative routes of measles immunization: a review. Biologicals. 25(3):1997;323-338.
11. Sabin A.B. Immunization against measles by aerosol. Rev. Infect. Dis. 5(3):1983;514-523.
12. Sabin A.B., Albrecht P., Takeda A.K., Ribeiron E.M., Veronesi R. High effectiveness of aerosolized chick embryo fibroblast measles vaccine in seven-month old and older infants. J. Inf. Dis. 152(6):1985;1231-1237.
13. Garenne M., Leroy O., Beau J.P., Sene I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet. 338:1991;903-907.
14. Krugman S. Medical progress: the clinical use of gamma globulin. N. Engl. J. Med. 269:1963;195-201.
15. Giraudon P., Wild T.F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology. 144:1985;46-58.
16. Malvoisin E., Wild T.F. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J. Virol. 64:1990;5160-5162.
17. Lipsey A.I., Kahn M.J., Bolande R.P. Pathological variants of congenital hypogammaglobulinemia: an analysis of three patients dying of measles. Pediatrics. 69:1967;659-674.
18. van Binnendijk R.S., Poelen M.C.M., Kuijpers K.C., Osterhaus A.D.M.E., Uytde-Haag F.G.C.M. The predominance of CD8 T-cells after infection with measles virus suggests a role for CD8 class 1 MHC-restricted cytotoxic T-lymphocytes (CTL) in recovery from measles. J. Immunol. 144:1990;2394-2399.
19. Beauverger P., Cardoso A.I., Daviet L., Buckland R., Wild T.F. Analysis of the contribution of CTL epitopes in the immunobiology of morbillivirus infection. Virology. 219:1996;133-139.
20. Drillien R., Spehner D., Kirn A., Giraudon P., Buckland R., Wild T.F., Lecocq J.P. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutin or fusion protein. Proc. Natl. Acad. Sci. USA. 85:1988;1252-1256.
21. Wild T.F., Bernard A., Spehner D., Drillien R. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. J. Gen. Virol. 73:1992;359-367.
22. d-restricted nucleoprotein epitope. J. Gen. Virol. 74:1993;2357-2363.
23. van Binnendijk R.S., Poelen M.C.M., van Amerongen G., de Vries P., Osterhaus A.D.M.E. Protective immunity in macaques vaccinated with live attenuated recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J. Inf. Dis. 175:1997;524-532.
24. Galetti R., Beauverger P., Wild T.F. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses. Vaccine. 13:1995;197-201.
25. Taylor J., Weinberg R., Tartaglia J., Richardson C., Alkhatib G., Breidis D., Appel M., Norton E., Paoletti E. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutin (HA) glycoproteins. Virology. 187:1992;321-328.
26. Morein B., Sundquist B., Höglund S., Dalsgaard K., Osterhaus A.D.M.E. Iscom, a novel structure from antigenic presentation of membrane proteins from enveloped viruses. Nature. 308:1984;457-460.
27. Cardoso A.I., Blixenkrone-Moller M., Fayolle J., Liu M., Buckland R., Wild T.F. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell mediated immunity. Virology. 225:1996;293-299.
28. Cardoso A.I., Sixt N., Vallier A., Fayolle J., Buckland R., Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by both the antigen and the coimmunized antigen. J. Virol. 72(3):1998;2516-2518.
29. Yang K., Mustafa F., Valsamakis A., Santoro J.C., Griffin D.E., Robinson H.L. Early studies on DNA-based immunizations for measles virus. Vaccine. 15(8):1997;888-891.